Aetna Orthovisc Prior Authorization Update: What Changed in October 2026
Aetna removed its commercial precertification requirement for Orthovisc (J7324), effective October 1, 2026. Practices should update their authorization workflow for applicable patients while continuing to verify coverage and document medical necessity. The announcement does not remove Orthovisc authorization requirements for Aetna Medicare plans.
For orthopedic practices, the immediate opportunity is to stop unnecessary authorization work without overlooking the checks that still support payment. The change is listed in Aetna’s October 2026 OfficeLink Updates.
What your practice should do now
Confirm the plan: Verify the patient’s exact coverage and requirements for the date of service.
Update the checklist: Remove outdated Orthovisc authorization steps where this change applies.
Keep supporting documentation: Continue checking benefits and medical necessity.
Review payment: Follow claims through adjudication and investigate denials.
Does this apply to other knee injections or Medicare Advantage?
The Orthovisc removal is listed specifically for commercial plans. Do not extend it to Aetna Medicare Advantage or other viscosupplement products without checking those requirements separately.
Organize authorization guidance by payer, plan and drug. A blanket instruction such as “Aetna knee injections do not need authorization” is too broad and can cause staff to skip a required check.
Does no prior authorization mean guaranteed payment?
No. An authorization requirement and a coverage determination are separate. Removing precertification does not establish that every patient or injection series is covered.
Aetna’s commercial viscosupplementation policy still sets out medical-necessity criteria, including diagnosis, functional symptoms, prior treatment and requirements for repeat series. Medicare requirements must be checked separately.
Before treatment, verify benefits and the applicable policy, confirm that documentation supports the planned service, and retain the dated verification or payer reference with the account.
What if an Orthovisc claim is denied for missing authorization?
Confirm that the service date and plan fall within the announced change.
Review the submitted claim, including the product code and other billing details.
Check the actual denial reason. Separate an authorization denial from medical necessity, a benefit exclusion or another issue.
If the denial conflicts with the applicable requirements, request a supported review using the Aetna notice and your verification records.
Do not assume the change reverses earlier denials. Apply the requirements in effect for the date of service.
For unresolved balances, assign an owner and a next step instead of repeatedly resubmitting the same claim. Our guide to reducing medical accounts receivable over 90 days explains how to prioritize that work.
How Horizon Can Help With Injection Billing
Denied or underpaid injection claims deserve a closer look. We can review your billing workflow, identify gaps in authorization and claim follow-up, and help pursue outstanding payments.
Call (408) 444-8845 for a complimentary billing review to identify what may be holding up your injection payments.
Comments